Continue to develop and industrialize of immune diagnostic reagents based on genetic recombination technology and monoclonal antibody technology, all of which are exclusive domestic technologies. We will provide the world’s highest level of diagnostic system to the customer.
11.Developed the world's first PRRSV-specific antibody detection method
11.Attract investment in Stick Investment
04.US Local Corporation Established (MEDIAN Life Science LLC.)
05.Completion and relocation of the factory to 878 street Chuncheon, Gangwon-do